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Abstract 
Background: The aim of this study was to explore the experiences of patients who suffer from acute cutaneous 
leishmaniasis in Iran, focusing on quality of life. 
Methods: The study was conducted at two different sites in Iran in 2010–2011. Individual in-depth interviews were 
conducted with six men and six women parasitologically confirmed acute cutaneous leishmaniasis. Interviews were 
recorded, transcribed verbatim, and translated into English. Qualitative content analysis was used for data analysis. 
Results: The participants, aged 23 to 63yr, had mild to severe disease. Based on the analysis four main themes were 
developed. "Fearing an agonizing disease" reflects patients' experiences of disease development resulting in sadness 
and depression, "struggling to cope" and "taking on the blame" both illustrate how patients experience living with the 
disease, which included both felt and enacted stigma as major social concerns. "Longing for being seen and heard" 
refers to patients' experiences with healthcare as well as their expectations and demands from communities and 
healthcare to be involved in closing the knowledge and awareness gap. 
Conclusion: Mental and social dimensions of cutaneous leishmaniasis were complex and adversely affected patients' 
lives by causing psychological burden and limiting their social interactions. Health authorities have to plan programs 
to increase the disease awareness to prevent the existing stigma to improve patients' social condition and medical care. 
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Introduction 
 
Leishmaniasis is a neglected tropical dis-
ease (1). Leishmaniases are a group of diseases 
caused by different species of the intracellu-
lar protozoan, Leishmania (2). The parasite is 
transmitted by the bite of infected sand flies. 
The disease is endemic in 98 countries, mostly 
developing ones. About 350 million individ-
uals are at risk of getting different types of 
leishmaniasis worldwide, and 1.5–2 million 
new cases of leishmaniasis occur each year, of  
 
 
which 75% are cutaneous (1-4). The majority 
of cutaneous leishmaniasis (CL) cases occur in 
ten countries: Afghanistan, Algeria, Brazil, Co-
lombia, Costa Rica, Ethiopia, Iran, Peru, Su-
dan and Syria (1). 
Iran is endemic for CL and almost all CL 
cases in Iran are caused by either L. tropica 
or L. major and in 2012, the Iranian Ministry 
of Health (MoH) registered 16597 and 4350 
cases, caused by L. major and L. tropica, re-
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spectively (4). However, the real number of 
CL cases could be as high as 100000 cases 
per year (2). 
From a clinical perspective, almost all 
acute Old World CL (AOWCL) cases in Iran 
can be divided into two forms: anthroponotic 
cutaneous leishmaniasis (ACL) and zoonotic 
cutaneous leishmaniasis (ZCL). ACL is also 
known as dry, urban or late ulcerative form 
and is generally attributed to L. tropica. ZCL 
which is caused by L .major is also known as 
wet, rural, or early ulcerative form CL. In hu-
man, the initial sign of infection is the appear-
ance of an erythematous papule or nodule at 
the feeding site of the female sand fly. It ap-
pears within one week to three months after 
sand fly bite. In a typical ZCL infection, the 
primary lesion usually develops into an ulcer 
with a violaceous border, which heals spon-
taneously after several weeks or months, re-
sulting in a scar. Ulceration is not a charac-
teristic feature of ACL lesions. Due to pres-
ence of a thick adherent scale on the lesion, 
hyperkeratosis is the dominant feature of 
ACL lesions (5-7). Many treatment modali-
ties have been used in the treatment of CL, 
but pentavalent antimony including meglu-
mine antimoniate (MA) are considered as the 
first line drugs for treatment so far. They 
have to be administered only as intramuscu-
lar, intravenous or intralesional injections and 
could be associated with severe side effects 
and significant discomfort (8). There is lack 
of strong evidence regarding effective, safe 
and inexpensive treatments for AOWCL (8, 
9). There is no vaccine available for preven-
tion of CL for general human use (10). 
The psychosocial impact of CL has been 
studied in a few quantitative papers. In Tur-
key, patients with CL had significantly high-
er levels of anxiety and depression and were 
less satisfied with their body image as com-
pared to controls (11). CL patients with ac-
tive lesions also had a more reduced quality 
of life (QoL) in comparison with patients with 
healed scars (11). Using Dermatology Qual-
ity of Life Index (DLQI) in Kerman, Iran, CL 
had a moderate to very high effect on the QoL 
of about 40% of patients (12). The most af-
fected domain was "symptoms and feelings" 
(12). Using DLQI and SF-36, "Symptoms and 
feelings" was also detected as the main af-
fected domain in another study from Iran 
(13). In Kabul, Afghanistan, based on focus 
group with women, CL implies being social-
ly excluded from communal life and illustrated 
how CL can cause both social and emotional 
trauma (14). However, to the best of our 
knowledge, there are no published qualita-
tive papers focusing on capturing individual 
experiences of living with CL in Iran.  
The aim of this study was to explore per-
ceptions and experiences among patients liv-
ing with CL as a basis for developing a dis-
ease-specific questionnaire focusing on qual-
ity of life in CL patients. 
 
Materials and Methods 
 
Study setting 
The study was conducted at two different 
sites in Iran: Center for Research and Training 
in Skin Diseases and Leprosy (CRTSDL), 
Tehran University of Medical Sciences lo-
cated in Tehran capital of Iran, which is a 
referral center for CL patients in Iran with 
about 140CL patients per year referred from 
all over Iran (15), and Golabchi Clinic in 
Kashan about 210 kilometer south of Tehran, 
where CL is endemic (16). The aim was to 
represent experiences from patients living in 
CL endemic (Kashan) and non-endemic (Teh-
ran) areas of Iran. 
 
Study design 
We used a qualitative study designed based 
on individual in-depth interviews since we were 
interested in the lived experiences of patients 
with the diagnosis of CL. Qualitative content 
analysis to capture the manifest and latent 
meaning of their experiences were used as a 
framework for analyzing the data (17). 
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Sampling of informants 
Informants were sampled purposively to 
reach maximum variation in regards to the 
severity of their disease. All informants were 
parasitologically confirmed CL case. In Teh-
ran, direct smear, culture on NNN (Novy-
McNeal-Nicolle), medium, and polymerase 
chain reaction (PCR) were used for CL diag-
nosis confirmation. Direct smear was the used 
technique in Kashan for parasitological con-
firmation. According to expert opinions and 
for practical reasons, CL severity was cate-
gorized in three levels: mild, moderate and 
severe. Patients with more than 5 lesions, le-
sions larger than 5mm in the largest diameter 
of induration, ulcerative lesions on the face, 
and sporotrichoid lesions were classified as 
"severe" cases. Patients with only one or 2 
lesions with the largest diameter less than 
30mm on locations other than face and ears 
were considered as "mild" cases and patients 
within between lesion number and size were 
defined as cases with "moderate" disease. 
We aimed to capture experiences from 
both men and women. Healthcare profes-
sionals at the two clinics (in Tehran and in 
Kashan) asked patients that fulfilled the above 
criteria if they were interested to participate 
in the study. If so they were contacted and 
informed about the aim of the study to settle 
on time and place for the interviews. 
 
Data collection 
Data collection took place from Oct 2010 
to Nov 2011. All interviews were conducted 
face-to-face at the respective clinics in rooms 
that allowed for privacy. All interviews were 
digitally recorded and followed a thematic 
guide including three main content areas: "dis-
ease development", "living with the disease", 
and "healthcare and community". During and 
after the interviews reflective notes were taken 
by the interviewer to facilitate elaboration on 
important issues in the forthcoming interviews. 
The interviews took between 40–75min. 
In total, twelve interviews were held with  
three men and three women recruited at 
CRTSDL and three men and three women at 
Golabchi Clinic. These interviews were re-
garded sufficient to capture the range of ex-
periences and in the last interviews, not much 
new information emerged. 
 
Analysis 
All interviews were transcribed verbatim 
into Persian and later translated into English 
to facilitate joint analysis within the research 
group. The analysis followed the procedures 
suggested by Graneheim and Lundman (17). 
This implied condensing the identified mean-
ing units prior to coding the text. Codes were 
later clustered and categories and sub-cate-
gories were developed to capture the mani-
fest meaning of the text. Finally, themes were 
constructed to interpret the more latent mean-
ing. During the analysis process, the inter-
pretation was continuously discussed in the 
research group. An example of the process of 
analysis from condensed meanings to codes, 
subcategories, and categories is presented in 
Table 1. 
 
Table 1. An example of analysis process from condensed meaning units to categories 
 
Condensed meaning unit Code Subcategory Category 
"I became sad when I got CL. Probability of re-
maining scars is annoying" 
Becoming sad, fearing remain-
ing scars 
Becoming sad Sensing 
responsibility 
"When I see people avoiding me because of my CL, 
or when they think it is communicable, I feel sad." 
People avoid me, think it is 
communicable, making me sad 
"My lesion's appearance is awful. I dislike it" Disliking own appearance Reacting with self-
disgust 
"I became angry after I got CL" Becoming angry Feeling angry 
"I regret that I did not use a bed net and I got CL" Regretting not using bed-net Regretting own acts 
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Ethical considerations 
The study protocol and its attachments 
were reviewed by the Ethical Committee of 
Research in Medical Sciences of CRTSDL, 
Tehran University of Medical Sciences, Teh-
ran, Iran, and the study received clearance on 
Dec 1, 2007. 
Prior to starting the interviews, the in-
formants were asked for written consent and 
for permission to record. The interviewer gave 
the informed consent form to each eligible 
participant prior to the interviews. The in-
formed consent form clearly indicated how 
confidentiality would be kept and that partic-
ipation was voluntary and would not influ-
ence the medical treatment. The whole ses-
sion would be recorded. Participants were 
asked to read the form carefully and were 
provided with further clarifications if needed 
before signing the form. 
If the patients needed treatment, they were 
treated free of charge. The study was conducted 
in accordance with the Declaration of Helsinki. 
 
Results 
 
Twelve patients were from 23 to 63yr old 
and all had got CL in the endemic areas. 
Those who lived in Tehran got it during trav-
els to endemic areas and those who got in 
Kashan were living in Kashan or its suburbs. 
Numbers of male and female participants were 
equal. Four cases had mild CL, another four 
had moderate CL, and the rest of them suf-
fered severe CL (Table 2). 
The analysis of the interview texts re-
sulted in four main themes: "Fearing an ago-
nizing disease", "Taking on the blame", "Strug-
gling to cope", and "Longing for being seen 
and heard" (Table 3). 
The themes reflect four content areas elab-
orated in the interviews. The first covers pa-
tients' experiences of disease development 
while the second and third themes illustrate 
how the patients experience living with CL. 
The last theme refers to patients' experiences 
with the healthcare system, their expectations, 
and their demands. The results are presented 
under the headings of the themes with cat-
egories as sub-headings and subcategories in-
corporated in the text in italics. Examples of 
quotations from the interviews are used to 
illustrate how the interpretation is linked to 
the data. The quotes are labeled with T1-6 and 
K1-6 for patients from Teheran and Kashan, 
respectively. 
 
Table 2. Demographic and clinical characteristics of the interviewees 
 
# Sex 
Age 
(Years) 
Occupation 
City of Residence 
(Where CL was got) 
CL Severity 
T1 Female 48 Teacher Tehran (Mashhad) Moderate 
T2 Female 45 Housewife Tehran (Damghan) Severe 
T3 Male 27 Caretaker Tehran (Damghan) Severe 
T4 Male 33 Bookbinder Tehran (Zavareh) Mild 
T5 Male 34 Aircraft fueler Tehran (Shiraz) Moderate 
T6 Female 38 Teacher Tehran (Zavareh) Mild 
K1 Female 31 University student Kashan (Kashan) Moderate 
K2 Male 50 Well excavator Ravand (Ravand) Moderate 
K3 Male 63 Businessman Ravand (Ravand) Severe 
K4 Male 40 Scrap dealer Ravand (Ravand) Mild 
K5 Female 40 Housewife Kashan (Ravand) Mild 
K6 Female 23 University student Kashan (Kashan) Severe 
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Table 3. Summary of main finding indicating themes, categories, and sub-categories 
 
Content area Category Theme 
Disease development Understanding the disease gradually Fearing an agonizing disease 
 Perceiving early skin lesions 
 Considering other skin diseases 
Feeling disease's mental impact 
 Starting to worry about consequences 
 Being physically and socially limited 
Living with the disease Sensing responsibility Taking on the blame 
 Regretting own acts 
 Feeling angry 
 Reacting with self-disgust 
 Becoming sad 
Facing stigma 
 Being rejected 
Feeling isolated 
 Finding themselves excluded 
Preventing others' reactions Struggling to cope 
 Hiding disease or self 
 Avoiding close contact 
Internalizing reactions from others 
 Understanding others reactions 
 Tolerating others behavior 
 Appreciating others' support 
Healthcare and community Finding treatment difficult but acceptable Longing for being seen and heard 
 Feeling the need for medical care 
 Playing little role in treatment schemes 
 Being satisfied with treatment results 
Noting limited knowledge on CL 
 Meeting unawareness in the community 
 Experiencing ignorance within the 
healthcare system 
Urging for prevention 
 High treatment costs 
 Considering current preventive methods as 
unsatisfactory 
 
 
Fearing an agonizing disease 
This theme captures patients' worries 
when they first experience symptoms and 
how these are perceived as scary and threat-
ening. The supporting categories show how 
some of the clinical characteristics and the 
course of the CL lesions affect the patient's 
mental status. 
 
Understanding the disease gradually 
The patients perceived early CL lesions 
to resemble many other skin disorders, for 
example, simple insect bites, boils, or aller-
gic reactions. 
 
However, CL did not follow the usual 
courses of an insect bite or other aforemen-
tioned diseases, which were expected to heal 
within a few days. Patients' confusion be-
came more evident when the lesions grew 
instead of healing. They considered other 
skin diseases and started to worry. In par-
ticular, for those who were not familiar with 
the disease, this enlargement, and progres-
sion of the lesions, associated with develop-
ment of relatively big, red, wounded, some-
times painful skin lesions, was worrying. 
Symptoms and signs of CL could be quite 
perplexing as described below: 
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"… It was itching and red, then it became 
larger, like the size of a pea. It was itching and 
burning. After two months it became larger 
and still was itching. Then it became puru-
lent. I tried to drain the purulent material my-
self several times, but each time the wound 
appears again and become purulent." T3. 
 
Feeling the disease's mental impact 
Feeling mental trauma because of CL 
was due to different experiences. Some pa-
tients were afraid because they misdiagnosed 
their own disease with more serious disease, 
commonly those known to be contagious, stig-
matizing diseases and notorious for being 
difficult to manage: 
"I thought I might have shaken hand with 
someone who has had AIDS or something. 
Or maybe that person's hand was bleeding 
and I had a wound on my hand too…so, I 
might get it [AIDS]." K4. 
These experiences together with misdi-
agnosis by healthcare providers made the pa-
tients fearing an agonizing disease. A patient 
said that a general physician made a diagno-
sis of a mosquito bite and prescribed him 
some antihistaminic tablets and an anti-pru-
ritic ointment, which were not effective. Pa-
tients' experiences of worrying about dif-
ferent aspects of the disease including its 
course and its outcome contributed to find-
ing CL a disease, which causes mental trau-
ma and preoccupation. Interestingly, in some 
patients, a confirmed diagnosis of CL was 
relieving to some extent, although the worry-
ing about long-term outcomes remained: 
"I was anxious for myself because of un-
certainty about the condition [I got] and what 
will happen to it.… I was relieved after CL 
diagnosis was made because of knowing that 
it was curable. However, I was worrying 
about the remaining [CL] scar". T1  
This patient showed how starting to wor-
ry about CL consequences could make CL a 
disease, which adversely affected patients' 
mental health. Other factors such as having 
limited knowledge about spreading and 
transmission routes of CL also contributed to 
this mental impact. 
They limited knowledge of patients about 
their own disease was associated with dis-
tress and having enough information about 
their CL would facilitate understanding their 
disease: 
"It is better for a person who knows 
[about CL]. If he/she knows about CL he/she 
would not be worried. The person who does 
not know it feels under pressure… A patient 
who knows about CL could cope better with 
the disease." K4. The patients experienced 
CL as a being socially and physically limit-
ing. Some patients experienced physical lim-
itations which were mainly related to the in-
terfering nature of the CL lesions with their 
daily work:  
"Since my job is basically done using my 
hands, an elbow [CL] lesion has adverse ef-
fects on my performance" T4, or: 
"My work is dealing with metal scraps. 
When I got CL, I could not work for about 
one month. I had to get a worker to do the 
job for me…I could not touch the industrial 
waste [metal scraps]". K4. 
Social limitations were more related to be-
coming isolated, rejected, and even stigma-
tized which is also described under the theme 
"struggling to cope". Being physically and so-
cially limited contributed to CL being associ-
ated with mental impact. 
 
Taking on the blame 
"Taking on the blame" is one of two 
themes that illustrate how CL patients expe-
rienced living with their disease. It repre-
sents the internal aspects of living with CL.  
 
Sensing responsibility 
Regretting own acts for getting CL showed 
how some CL patients acknowledged their own 
role in getting the disease and sensing their 
responsibility: 
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"I regret that I did not use a bed net and I 
got CL" T2. 
Some CL patients felt anger, which might 
adversely affect their relations with co-work-
ers and family members. For example, a man 
with severe CL recalled: 
"After I got CL I became irritable and 
moody. On one occasion, I became really an-
gry at my workplace when someone hit my 
elbow for fun. Moreover, at home, there was 
one occasion that my wife asked me to help 
her for preparing the bed but I told her that I 
would not help. I became so angry, that I 
went to another room for sleeping and told 
her that my hand is painful and I could not 
even pick up a 1-kg weight. …Anger was 
because of getting CL." T3. 
Becoming angry was related to sensing 
responsibility because the patient felt respon-
sible for doing something he was expected to 
do or avoiding something that he was ex-
pected to do as a result of his anger. React-
ing with self-disgust and becoming sad were 
other sub-categories contributing to sensing 
responsibility. 
"I am really sad because I find my CL le-
sions disgusting. Their appearance is very bad 
and they are really awful. I always say pray-
ers that it [CL] be completely cured as fast as 
possible." T1. 
 
Facing stigma 
Some prominent experiences in CL pa-
tients were feelings of being rejected, isolat-
ed, and excluded. These experiences showed 
both enacted and felt stigmatization: 
"…Everyone is scared of CL. Like in the 
mosque that I used to go, there was a woman 
who had CL where everybody could see her 
lesions. Nobody would sit beside her or shake 
hands with her. People pointed her out to each 
other and talked about her. … She was lone-
ly. … When they stood in lines for prayers 
(Namaz), people stood away from her at a dis-
tance…When I got CL, I experienced these 
matters myself." K6, or: 
"In the bank, once they saw my [CL] 
wound, they looked away [dropped their head]. 
Or in the bakery when I touched the bread to 
give it to someone, they threw the bread 
away. It is because of infection [CL]." K4. 
In some cases, the feelings were so over-
whelming that the patients felt being stigma-
tized and used the exact word of stigma or 
being stigmatized to describe their situation: 
"I feel being stigmatized after getting CL. I 
think this stigmatization is imposed by close 
friends as well as distant ones [local shop-
keeper]." T1. 
 
Struggling to cope 
This theme also reflects patients' experi-
ences of living with CL. However, while the 
theme "taking on the blame" basically refers 
to patients' own role, "struggling to cope" 
illustrates how CL patients' react to other peo-
ple reactions, one of the less explored as-
pects of the CL patients. CL patients' inter-
actions with others were spread over a wide 
spectrum of somewhat contradictory expe-
riences illustrated by two main strategies 
used to handle others reactions towards their 
disease. 
 
Preventing others' reactions 
The first strategy was to prevent reactions 
from other people to happen, basically through 
hiding the lesion or self. An example of this 
preventive mechanism was evident from these 
quotations: 
"Even if my brother comes to our home I 
wear a long-sleeved dress, so they [he] can-
not see this part of my elbow." T1, or: 
"Even you may want to hide." T4.  
For some patients, it was quite upsetting 
and discouraging to constantly feel forced to 
inform about their disease. This even result-
ed in telling lies to avoid more distress: 
"I did not fear [others reactions], but I was 
upset that I was being asked about it [CL] all 
the time, like every 5 to 10min, from my uni-
versity to home I should have explained it for 
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20 people. That bothered me. I did not like to 
answer. In the beginning, I told them it was 
CL and then I observed that everyone, from 
young to old, run away from me. They did 
not take a sandwich or a glass of water from 
me. The problem was that I had to lie to them 
to make myself feel more comfortable. I would 
say it was wart and people stopped asking ques-
tion when they thought it was wart. Lying to 
people bothered me. But it was a white lie, it 
was better than my suffering [for being asked 
about my lesions too frequently]".K6. 
 
Internalizing reactions from others 
The second strategy was to see the dis-
ease through the eyes of others by indicating 
that they understood others' reactions towards 
them. Some preferred to use the term "toler-
ating" instead of "understanding", indicating 
that while they could not understand or find 
a rationale for others' reactions, they tried to 
accept the situation they were in: 
"I thank God that I am really tolerant and 
I do not struggle with people. I tell my col-
leagues that I have CL and ask them to hit 
[as a sign of friendship] on my healthy arm 
instead of the affected one." T3. 
At the same time patients experienced 
others' support: 
"In my case, they [my colleagues] gave 
me my injections at the workplace, although 
if they did not, I would go somewhere to 
receive them. They also gave me some leave. 
… I told them that I recovered, but they told 
me that I have not recovered yet. They told 
me that I follow up my disease and if I need 
something for example money, I phone 
them. …". 
 
Longing for being seen and heard 
The last theme reflects CL patients' en-
counters with the healthcare system. CL pa-
tients experienced being ignored, and exclud-
ed from shared decision making for treatment 
plans, and not receiving proper acknowl-
edgement for their own treatment demands. 
It is also related to the patients' experiences 
in the communities, in which people have 
limited knowledge about CL or despite hav-
ing enough information on the disease, they 
do not behave in accordance with what they 
know.  
 
Finding treatment difficult but acceptable 
CL treatment was not easy because of its 
associated side effects. However, when they 
felt they would benefit they tended to accept 
the treatment offered. 
"I feared of [MA] injections. Once, I re-
ceived incomplete treatment because of [in-
jection] pain, but later on I completed the 
[treatment] course. CL treatment course is 
shorter than the courses for some other health 
problems. I feel happy about the results of 
the treatment of CL." T3, or: 
Feeling really uncomfortable also con-
tributed to needing medical care because of 
the severity of the disease 
"When I became uncomfortable because 
of the pain and itch on my CL lesion, I decided 
to go to a doctor… I knew that CL would 
finally heal [spontaneously], but I decided to 
seek medical advice on its treatment…" T5. 
Some patients were prepared to tolerate 
quite painful complications in order to quick-
en the healing phase. 
"When I received [MA] injections, I felt 
some malaise … I felt that [MA] injections 
caused problems for my kidneys because I 
had to wake up during the nights and go to 
WC. But in general, the complications were 
not serious. I have prescribed 3 vials [of MA] 
each day for 2 weeks, a total of 42 injections. 
I received them intramuscularly and my [glu-
teal] muscle became very stiff, so I could not 
use the last 3 vials. I knew that [MA] injec-
tions would heal CL lesions in about 2 wk. I 
also knew that without treatment CL might 
take about 6 months to be healed." T4. 
Others felt that they did not play enough 
roles in making decision about the treatment 
of their disease and were not satisfied with 
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the physician's approach to treatment. They 
had wanted to be more involved even if they 
were satisfied with the treatment results. 
"I have to raise one point; my physician 
postponed my treatment for 10 d because he 
did not want to treat me with [MA] injec-
tions at first. He told me that the injections 
would be very painful and I might not be 
able to walk for some time after I received 
the [MA] injections, but when I received the 
injections, they were nothing extraordinary. I 
think that if he started my treatment earlier, 
my disease would not become so bad. I im-
agine patients do not actively participate in 
choosing the treatment methods. They play 
too little role in the treatment plan." T2. 
 
Noting limited knowledge on CL 
The participants described how they met 
unawareness in the community and clearly 
saw how this was one of the important fac-
tors increasing their suffering: 
"…I am a sportswoman and I [have to] 
wear clothes that are comfortable [which do 
not cover all parts of the body], and since 
many people do not know what it [CL] is 
and whether it is communicable or not, they 
ask questions or avoid me, and I have to 
wear certain clothes and also I will remain 
isolated". K1.  
However, it was not only in the commu-
nity that the participants had met ignorance 
about the disease. Even within the health 
care system, they experienced ignorance and 
suspicion resulting in them being treated as 
if the disease was highly transmissible. 
"Even once I went somewhere to receive 
my injection and the nurse who wanted to do 
the injection feared so much that she refused 
to inject the medicine… She thought that it is 
highly transmissible and feared a lot…." T4. 
Some had concrete suggestions of how to 
increase community awareness and under-
scored that the information given needs to be 
repeated regularly to really make a difference.  
"… Maybe not enough information [in the 
community]. They give people brochures about 
CL every 10yr, maybe. If these brochures and 
handouts are given to people every 2–3 months, 
once a year and everyone knows about CL 
and gets better education, it would become 
much better." K6. 
Others emphasized the importance to ad-
just the information provided to different 
groups of people and to write in an under-
standable language. 
"I would like to see more public educa-
tion about CL. There must be some public 
areas where people gather and discuss dif-
ferent aspects of the disease [CL]. The socie-
ty is full of people of different kinds, young, 
old, educated, illiterate, etc. The information 
should be easily understandable by every-
one. Not just a printed hand-out that they 
give to people." K1. 
 
Urging for prevention 
The participants also emphasized the 
need for prevention from different perspec-
tives. For those who were less economically 
privileged the urge for prevention was based 
on the high treatment costs: 
"The disease [CL] has to be prevented. You 
have to go after treatment, spend money for 
it. Have to look until you find a clue. When I 
was first bitten by CL [mosquito], I could not 
figure it out. I got unemployed. I spent money. 
…I had to pay for transportation fees." K2. 
However, the need for prevention was not 
raised only by the poor. Moreover, patients 
from households with moderate to high in-
comes not only acknowledged the importance 
of prevention but considered current preven-
tive methods as unsatisfactory: 
"I think CL prevention is very important. 
I hope a vaccine be developed for CL soon. 
Current preventive measures like using in-
sect repellent sprays and even using bed nets 
are not completely effective". T4. 
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Discussion 
 
Exploring the lived experiences of patients 
suffering from acute AOWCL indicated that 
the disease affects different aspects of the lives 
of the patients. While most physical problems 
of CL lesions were quite expectable, the mental 
and social dimensions of the disease were af-
fected much more than what it was thought. 
However, we noticed some important expe-
riences by the patients which were related to 
the course of the disease development and man-
agement. The adverse impacts of CL on men-
tal health started with facing an agonizing 
and fearing disease and continued with worry-
ing, anxiety, sadness, and depression. The main 
societal problem associated with CL was stig-
ma. These problems together with insufficient 
information about CL in general population and 
sometimes among healthcare providers result-
ed in the patients' struggle of coping with their 
situation and longing for being heard and seen 
by both ordinary people and health authori-
ties. Disseminating knowledge about CL in 
community and better training of healthcare 
professional could help to improve CL pa-
tients' conditions.  
CL was not a minor health problem (14). 
While it is not uncommon for other dermato-
logic diseases to be misdiagnosed by the pa-
tients and non-dermatologist physicians, CL 
misdiagnosis is quite agonizing for the pa-
tients because its clinical course is dramat-
ically different from what they expect. For 
example, a patient whose early CL lesion was 
misdiagnosed with an ordinary insect bite and 
received treatment for the latter, worried when 
he/she observed that instead of healing, his/ 
her lesion grew much larger and became pu-
rulent. According to our experience, patients 
might mistake CL with a wide spectrum of 
dermatological diseases from boils to skin tu-
mors, leprosy and HIV/AIDS infection. These 
misinterpretations of symptoms and signs were 
particularly evident when the patients had no 
previous information about CL. This associ- 
 
 
ation between knowing about CL and better 
QoL was also reported, patients without pre-
vious knowledge about CL has worse QoL in 
comparison with those who had previous 
knowledge about it (13). 
Depending on the location and severity 
of CL, it could result in physical limitations 
for the patients, which could consequently 
affect their income, because they were not 
able to do their jobs. However, the impact of 
unemployment and health expenditure in 
AOWCL is much smaller in comparison with 
some more chronic tropical diseases such as 
lymphatic filariasis (18). 
Lack of knowledge about CL among gen-
eral population was a contributing factor to 
the CL-associated stigma. Since Kashan is 
endemic for CL, it was reasonable to assume 
that similar to patients with CL, people with-
out CL in Kashan were quite familiar with 
CL and had a better understanding of CL 
patients’ situation. However, such understand-
ing was not reflected in their behavior to-
wards the CL patients. This finding was sim-
ilar to results (14), which indicated that while 
people in endemic areas for CL like Kabul, 
Afghanistan had an acceptable knowledge 
about several aspects of the disease, their be-
havior towards CL patients was not congru-
ent with their knowledge. 
Worrying about their disease and its con-
sequences including scar formation was a dom-
inant finding among our participants and some 
of them also mentioned that they became sad 
because they got CL. Our findings were sim-
ilar to results which showed significantly high-
er anxiety and depression in CL patients than 
healthy controls (11). Lower QoL and body 
image satisfaction in patients with active CL 
lesions in comparison with healthy individu-
als or those who had CL scars (11). 
An important and less explored aspect of 
CL is the psychological and social effects on 
the patient's lives. Our study contributes with 
J Arthropod-Borne Dis, June 2018, 12(2): 180–195                                                   A Khatami et al.: Lived Experiences of … 
190 
 
             http://jad.tums.ac.ir 
             Published Online: June 13, 2018 
examples of feelings and reactions in relation 
to themselves or other individuals that could 
result in psychiatric problems such as de-
pression. Our findings are supported by two 
studies from Iran's neighboring countries; Tur-
key and Afghanistan that found depression 
and anxiety were more frequent among CL 
patients (11, 14). Depression and sadness be-
cause of the disfigurement caused by filaria-
sis could have greater burden for the patients 
than its physical consequences (19). This great-
er burden of psychosocial impact could oc-
cur in CL patients as well. Regretting own 
acts and reacting with self-disgust could con-
tribute not only to sadness and depression 
but also to low self-esteem and social dis-
connection (19). 
Several definitions of stigma were pro-
vided (20), of which three, i.e. enacted, per-
ceived, and internalized stigma were de-
scribed in patients on another neglected trop-
ical disease, lymphatic filariasis. Our CL pa-
tients experienced different types of stigma. 
Some CL patients, mostly those with moder-
ate or severe disease, were rejected, feeling 
isolated or finding themselves excluded which 
could be considered as examples of enacted 
stigma (19, 20). Among the management 
strategies for this kind of stigma, the patients 
used denial by telling lies about their disease 
and hiding their lesions. When they talked 
about their experiences, some of our partici-
pants said some matters that indicated per-
ceived (felt) stigma, such as being aware of 
other who had CL and experienced discrim-
ination. They were afraid of being treated like 
those whom they had heard about. Their man-
agement strategies were similar to patients who 
suffered filariasis including modifying social 
interactions, isolating self, and hiding the af-
fected body parts (19). We also found exam-
ples of internalized (self) stigma in our inter-
views with CL patient like regretting own 
acts (i.e. guilt), reacting with self-disgust, and 
sadness (19). CL patients with internalized 
stigma used the same management strategies 
(19) of women with filariasis. Another type 
of stigma was defined "aesthetic" or "unaes-
thetic" stigma which is caused by visible marks 
or visible deformities (21-23). Since it was on 
CL stigma in Surinam that terminology might 
be relevant to our study as well (23) although 
we imagine that it does significant overlap 
with the three former stigmas we have al-
ready mentioned and is not a unique entity. 
Since CL is very common in some coun-
tries, to reduce the CL-associated stigma some 
strategies have been developed which could 
be considered cultural rather than individual 
(22, 24). One example is according to Desjeux 
that CL was known as ‘little sister’ in some 
endemic countries where it was very com-
mon and became part of normal life just as a 
family member (24). Another cultural man-
agement strategy to counteract CL stigma was 
pointed in Turkey, in which the older people 
were accustomed to the CL scar, and called 
it "a beauty scar" to increase the tolerability 
and normalization (22). However, the young-
er generations did not accept the CL disfig-
urement and scar and considered it as a life-
long stigma (22). Severe CL-associated stig-
ma was reported in Kabul Afghanistan, where 
the disease was very common and the people 
were knowledgeable about CL (14). This dif-
ference might be explained by lack of cultur-
ally-built management strategies regarding 
CL stigma. Because of some wrong believes, 
more than half of their studied cases men-
tioned that they would prevent a CL patient 
from touching and hugging his/her child, and 
they would not allow a CL patient prepare 
food in the home (14). In addition, more than 
20% of participant in their study said that a 
mother with CL should not breastfeed her 
child. Women with CL lesions or scar would 
face problem if they would like to marry (14). 
The CL stigma and its social impact in Af-
ghanistan were larger than what it is in Iran 
(14). 
According to some participants in our 
study, they tried to accept their situation and 
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acknowledge others' reactions toward their 
disease by trying to understand or at least 
tolerate the others. Even some of patients ap-
preciated others' supports. Therefore, these 
mechanisms together with some of the afore-
mentioned stigma management strategies 
helped the CL patients to continue their strug-
gle to cope. Provided an interesting discus-
sion about the potential roles of morals and 
contextual morals in de-stigmatization of 
health problems including depression, which 
might be used in combating CL-associated 
stigma when the knowledge about that issue 
become more clear in the future (25). They 
explained how stigmatized individuals were 
not able to meet the obligatory and norma-
tive moral criteria that were set in a context 
of a society by socio-economic, cultural, an-
thropological and political determinants. Ac-
knowledging the interconnection between those 
who stigmatize and those who were stigma-
tized (25) stated that understanding and chang-
ing the stigma-determining factors could help 
to combat stigma through modifying the con-
textual morals. 
In Dominican Republic and Ghana on 
lymphatic filariasis (19, 26), factors such as 
religious beliefs and hope provided the basis 
for better coping with the disease. Due to 
strong religious beliefs in most Iranians, this 
factor played a role for those who internal-
ized or integrated others' reactions. 
Determinants of the stigma associated with 
another neglected tropical disease, leprosy were 
reported, as visibility of the lesions, cultural 
and religious beliefs, fears of transmission and 
public health interventions (27). From the in-
terviews with patients and considering Iran's 
cultural context, it would be likely that the 
same determinants play roles in CL stigma. 
The association of visibility of the lesions with 
stigma in skin diseases is quite well known, 
not only in infectious diseases in developing 
countries but also in non-infectious diseases 
such as psoriasis and vitiligo in both devel-
oping and developed countries (28, 29). Ho-
tez provided a concise and interesting dis-
cussion about the importance of stigma in the 
burden of disease of neglected tropical dis-
eases including CL, which might be not be 
reflected in a quantitative indicator of dis-
ease burden like disability-adjusted life year 
(DALY) (30). Small DALYs of CL patients 
(31), from Iran, was in line with Hotez (30) 
conclusions and indicated the need for qual-
itative researchers to better explore the im-
pacts of CL on patients' lives. A multifaceted 
approach to target CL itself through increas-
ing the availability of affordable care for CL 
patients and to educate people about the dis-
ease was needed to reduce the social burden 
and the associated stigma of CL (32), we also 
imagine that developing and implementing 
healthcare educational and interactive de-
stigmatizing programs could play important 
roles to improve CL patients' situation. 
Despite the patients knew about the self- 
limiting nature of CL, they sought medical 
care form health professionals (14). Some pa-
tients found their encounters with healthcare 
providers were not satisfactory. They were 
misdiagnosed, they were not sufficiently en-
gaged in the decision-making process of treat-
ment, and even were behaved discriminately 
against. They were aware about the adverse 
effects of the standard treatment of and even 
experienced some of those complications; 
however, they decided to receive the recom-
mended therapeutic regimen. During the in-
terviews, several patients gave answers indi-
cating that they were aware of traditional 
methods of CL treatment provided by the 
traditional herbalists or recommended by their 
family members or friends, but they preferred 
to be treated by medical doctors. However, 
none of them had experienced a traditional 
therapeutic method. 
One of the issues that was surprising in 
our study was the fact that while, most inter-
viewees were quite knowledgeable about CL 
risk factors like exposure to sand-fly bites, 
routes of its transmission, and in some cases 
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about the clinical signs and symptoms, most 
patients acted similarly to individuals who 
were not familiar with the disease. The pa-
tients' experiences indicated that in endemic 
areas such as Kashan and Damghan, the gen-
eral populations were quite knowledgeable 
but still acted in a stigmatizing way towards 
CL patients. The patients attributed their ex-
periences to lack of knowledge in the com-
munity, although it might be not be explained 
only by this factor. Indeed, the CL-associ-
ated stigma might be a culprit. Most patients 
asked for better health education programs to 
tackle this problem. According to the pa-
tients, trained healthcare providers' knowledge 
about CL was also insufficient and CL pa-
tients asked for better training be provided 
by the responsible organization and authori-
ties such as MoH to improve the situation. 
We found it interesting that almost all in-
terviewees answered an open question about 
"what else they would like to add to what 
had already been talked about?", by empha-
sizing the lack of information and the existing 
ignorance about CL in the community. They 
asked for ways to increase the public aware-
ness with emphasis on the potential role of mass 
media especially Islamic Republic of Iran 
Broadcasting (IRIB) Television. They believed 
that visual programs could improve knowledge 
about CL in those who could not read news-
papers, educational pamphlets, and posters. 
The participants asked for more effective 
preventive methods. Although less socio-eco-
nomically privileged patients considered high 
treatment costs as a reason for improved pre-
ventive interventions, at least one study con-
ducted in an endemic area in Iran reported that 
with the exception of educational programs, 
applying other known preventive methods such 
as using insect repellants, pesticides, and bed-
nets were not cost-effective or cost-benefit-
ing (33). Using the Markov decision analytic 
computer model, development of a vaccine 
for CL with only 50% efficacy and as little 
as 5yr of protection in seven Latin American 
countries with highest incidences of CL in 
that region would be cost-effective in com-
parison with standard treatment regimens (34). 
However, the treatment cost per patient and 
the morbidity of New World CL is higher than 
Old World CL (33, 35). Development of new 
and more effective preventive methods such 
as vaccines was also one of the demands of 
relatively affluent CL patients in our study. 
Even if our interviewees were aware the get-
ting CL for the second time is very unlikely, 
they still were looking for more effective 
prevention methods. CL could be prevented in 
them, but also would be preventable for those 
who still had not experienced the disease. 
 
Trustworthiness 
Strengths 
The first author (AK) is an experienced 
dermatologist having worked with CL for 
several years at CRTSDL in Tehran and in 
endemic areas in Iran. To increase the credi-
bility of the study he made multiple visits to the 
endemic setting (Golabchi Clinic, in Kashan) 
to assess the situation, build trust with the 
clinic staff and to familiarize them with the 
research project. His prolonged engagement 
also included spending several weeks in the 
Kashan during the actual data collection pe-
riod. However, during the interviews, he made 
efforts to put his knowledge and experiences 
of CL as a dermatologist within brackets and 
allow the informants to tell their stories. The 
analysis was regularly discussed in debrief-
ing meetings within the research group in-
cluding interdisciplinary competencies. Taking 
field notes during his stay documenting the 
research process facilitated keeping and audit 
trail to account for the dependability of results. 
 
Limitations 
Only people sought medical care for their 
CL lesions were included in the study so in-
dividuals who had not been coming for med-
ical treatment were excluded. An expert pan-
el had been consulted and it was agreed that 
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it is unlikely that the experiences between the 
two groups were considerably different. CL 
requires medical care, which was taken as an 
indication that this would also be the situa-
tion in Iran (14). However, the transferability 
of our results is limited by only including 
patients with acute Old World CL (lesions du-
ration less than 6 months). Those who suffer 
from other forms of CL, which have longer 
duration, could be considerably different since 
they have other clinical courses and outcomes. 
For consent reasons our study only investi-
gated patients who were older than 18yr and 
we acknowledge this as a limitation since chil-
dren are a large and important group at risk 
of having CL in endemic areas. 
 
Conclusion 
 
Our study demonstrates how CL inter-
feres with patients' health, both mentally and  
socially. To provide a better management and 
reduce the burden of CL, in particular, its as-
sociated stigma, further studies to investigate 
the QoL of CL patients as well as developing 
and implementing health education programs 
in endemic areas are recommended.  
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